Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

Alexander Hein, Andreas D. Hartkopf, Julius Emons, Michael P. Lux, Bernhard Volz, Florin-Andrei Taran, Friedrich Overkamp, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Lena A. Wurmthaler, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Pauline Wimberger, Carsten Hielscher, Christian M. Kurbacher, Rachel Wuerstlein, Christoph Thomssen, Michael Untch, Peter A. Fasching, Wolfgang Janni, Tanja N. Fehm, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Hans-Christian Kolberg

Open source

DOI
10.1016/j.ejca.2021.06.033
Published
2021-09
Container
European Journal of Cancer
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2021.06.033,
  title = {Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status},
  author = {Alexander Hein and Andreas D. Hartkopf and Julius Emons and Michael P. Lux and Bernhard Volz and Florin-Andrei Taran and Friedrich Overkamp and Peyman Hadji and Hans Tesch and Lothar Häberle and Johannes Ettl and Diana Lüftner and Lena A. Wurmthaler and Markus Wallwiener and Volkmar Müller and Matthias W. Beckmann and Erik Belleville and Pauline Wimberger and Carsten Hielscher and Christian M. Kurbacher and Rachel Wuerstlein and Christoph Thomssen and Michael Untch and Peter A. Fasching and Wolfgang Janni and Tanja N. Fehm and Diethelm Wallwiener and Sara Y. Brucker and Andreas Schneeweiss and Hans-Christian Kolberg},
  year = {2021},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2021.06.033},
  url = {https://doi.org/10.1016/j.ejca.2021.06.033}
}

RIS

TY  - JOUR
TI  - Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status
AU  - Alexander Hein
AU  - Andreas D. Hartkopf
AU  - Julius Emons
AU  - Michael P. Lux
AU  - Bernhard Volz
AU  - Florin-Andrei Taran
AU  - Friedrich Overkamp
AU  - Peyman Hadji
AU  - Hans Tesch
AU  - Lothar Häberle
AU  - Johannes Ettl
AU  - Diana Lüftner
AU  - Lena A. Wurmthaler
AU  - Markus Wallwiener
AU  - Volkmar Müller
AU  - Matthias W. Beckmann
AU  - Erik Belleville
AU  - Pauline Wimberger
AU  - Carsten Hielscher
AU  - Christian M. Kurbacher
AU  - Rachel Wuerstlein
AU  - Christoph Thomssen
AU  - Michael Untch
AU  - Peter A. Fasching
AU  - Wolfgang Janni
AU  - Tanja N. Fehm
AU  - Diethelm Wallwiener
AU  - Sara Y. Brucker
AU  - Andreas Schneeweiss
AU  - Hans-Christian Kolberg
PY  - 2021
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2021.06.033
UR  - https://doi.org/10.1016/j.ejca.2021.06.033
ER  - 

APA

Hein, A., Hartkopf, A. D., Emons, J., Lux, M. P., Volz, B., Taran, F., Overkamp, F., Hadji, P., Tesch, H., Häberle, L., Ettl, J., Lüftner, D., Wurmthaler, L. A., Wallwiener, M., Müller, V., Beckmann, M. W., Belleville, E., Wimberger, P., Hielscher, C., Kurbacher, C. M., Wuerstlein, R., Thomssen, C., Untch, M., Fasching, P. A., Janni, W., Fehm, T. N., Wallwiener, D., Brucker, S. Y., Schneeweiss, A., & Kolberg, H. (2021). Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2021.06.033

Source records